McElhenny Sheffield Capital Management’s Labcorp LH Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,005	Closed	-$576K	–	110
2025 Q3	$576K	Sell	2,005 -7	-0.3%	-$1.88K	0.14%	42
2025 Q2	$528K	Hold	2,012	–	–	0.14%	44
2025 Q1	$468K	Buy	2,012 +1	+0%	+$243	0.18%	58
2024 Q4	$461K	Buy	2,011 +3	+0.1%	+$688	0.15%	58
2024 Q3	$449K	Buy	2,008 +5	+0.2%	+$1.1K	0.15%	63
2024 Q2	$408K	Hold	2,003	–	–	0.14%	64
2024 Q1	$438K	Sell	2,003 -5	-0.2%	-$1.1K	0.16%	60
2023 Q4	$456K	Hold	2,008	–	–	0.19%	55
2023 Q3	$404K	Sell	2,008 -329	-14%	-$69.4K	0.21%	56
2023 Q2	$485K	Sell	2,337 -11	-0.5%	-$2.13K	0.21%	53
2023 Q1	$463K	Buy	2,348 +14	+0.6%	+$2.88K	0.24%	60
2022 Q4	$472K	Buy	2,334 +3	+0.1%	+$586	0.22%	55
2022 Q3	$410K	Hold	2,331	–	–	0.31%	49
2022 Q2	$469K	Hold	2,331	–	–	0.22%	57
2022 Q1	$528K	Hold	2,331	–	–	0.18%	65
2021 Q4	$629K	Hold	2,331	–	–	0.24%	61
2021 Q3	$564K	Buy	+2,331	New	+$587K	0.26%	65

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

McElhenny Sheffield Capital Management's LH Position: Q4 2025 in Review

McElhenny Sheffield Capital Management sold out of Labcorp (LH) in Q4 2025, closing a stake of 2,005 shares — an estimated $576K sold.

McElhenny Sheffield Capital Management first reported a position in LH in Q3 2021 and held it in 17 quarters. The position peaked at $629K in Q4 2021. 1,025 funds tracked by Wall St. Rank hold LH as of Q4 2025.

McElhenny Sheffield Capital Management reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
McElhenny Sheffield Capital Management sold 2,005 Labcorp shares in Q4 2025, an estimated $576K.
McElhenny Sheffield Capital Management first reported a position in Labcorp in Q3 2021 and held it in 17 quarters.
McElhenny Sheffield Capital Management's Labcorp position peaked at $629K in Q4 2021.
1,025 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on McElhenny Sheffield Capital Management's 13F filing for Q4 2025, filed 21 Jan 2026.